A detailed history of High Tower Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 2,742,343 shares of MRK stock, worth $277 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
2,742,343
Previous 2,704,145 1.41%
Holding current value
$277 Million
Previous $357 Million 4.85%
% of portfolio
0.53%
Previous 0.58%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $4.73 Million - $5.08 Million
38,198 Added 1.41%
2,742,343 $340 Million
Q1 2024

May 06, 2024

SELL
$113.24 - $131.95 $7.41 Million - $8.64 Million
-65,477 Reduced 2.36%
2,704,145 $357 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $149,668 - $162,875
1,494 Added 0.05%
2,769,622 $302 Million
Q3 2023

Nov 08, 2023

BUY
$102.95 - $114.33 $3 Million - $3.33 Million
29,095 Added 1.06%
2,768,128 $285 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $4.72 Million - $5.15 Million
43,493 Added 1.61%
2,739,033 $316 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $23.7 Million - $26.4 Million
-230,247 Reduced 7.87%
2,695,540 $287 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $7.01 Million - $8.98 Million
80,118 Added 2.82%
2,925,787 $325 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $1.3 Million - $1.46 Million
-15,407 Reduced 0.54%
2,845,669 $245 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $2.03 Million - $2.3 Million
24,313 Added 0.86%
2,861,076 $261 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $9.09 Million - $10.2 Million
123,627 Added 4.56%
2,836,763 $233 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $21.2 Million - $26.6 Million
293,535 Added 12.13%
2,713,136 $208 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $5.44 Million - $5.98 Million
75,827 Added 3.24%
2,419,601 $182 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $16.8 Million - $18.5 Million
238,378 Added 11.32%
2,343,774 $182 Million
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $4.68 Million - $5.51 Million
67,894 Added 3.33%
2,105,396 $162 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $7.11 Million - $7.89 Million
99,063 Added 5.11%
2,037,502 $167 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $5.18 Million - $5.87 Million
70,824 Added 3.79%
1,938,439 $161 Million
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $7.53 Million - $8.57 Million
106,954 Added 6.07%
1,867,615 $144 Million
Q1 2020

May 21, 2020

SELL
$63.36 - $87.82 $329,598 - $456,839
-5,202 Reduced 0.29%
1,760,661 $135 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $4.35 Million - $4.91 Million
56,088 Added 3.28%
1,765,863 $161 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $2.31 Million - $2.52 Million
30,390 Added 1.81%
1,709,775 $144 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $4.45 Million - $5.2 Million
-63,742 Reduced 3.66%
1,679,385 $141 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $2.05 Million - $2.34 Million
-29,511 Reduced 1.66%
1,743,127 $145 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $882,370 - $1.02 Million
13,525 Added 0.77%
1,772,638 $135 Million
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $3.42 Million - $4.02 Million
-59,314 Reduced 3.26%
1,759,113 $125 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $1.01 Million - $1.19 Million
19,942 Added 1.11%
1,818,427 $110 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $12.2 Million - $14.2 Million
239,055 Added 15.33%
1,798,485 $97.9 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $3.56 Million - $4.25 Million
-68,949 Reduced 4.23%
1,559,430 $87.8 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $2.59 Million - $2.79 Million
44,194 Added 2.79%
1,628,379 $104 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,584,185
1,584,185 $101 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.